U.S. market Closed. Opens in 7 hours 36 minutes

CAPR | Capricor Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 18.56 - 19.70
52 Week Range 2.6800 - 23.40
Beta 1.08
Implied Volatility 135.85%
IV Rank 7.41%
Day's Volume 1,100,570
Average Volume 2,987,403
Shares Outstanding 45,463,000
Market Cap 845,384,485
Sector Healthcare
Industry Biotechnology
IPO Date 2007-02-13
Valuation
Profitability
Growth
Health
P/E Ratio -20.89
Forward P/E Ratio N/A
EPS -0.89
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 101
Country USA
Website CAPR
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.
*Chart delayed
Analyzing fundamentals for CAPR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see CAPR Fundamentals page.

Watching at CAPR technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on CAPR Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙